Form 8-K - Current report:
SEC Accession No. 0001087294-14-000006
Filing Date
2014-03-07
Accepted
2014-03-07 17:13:00
Documents
4
Period of Report
2014-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K cpix2013-earningsrelease.htm 8-K 29235
2 EXHIBIT 99.1 exhibit991vaprisolacquisit.htm EX-99.1 22502
3 EXHIBIT 99.2 exhibit992earningsrelease.htm EX-99.2 243892
4 cumberlandpharmalogo.jpg GRAPHIC 37721
  Complete submission text file 0001087294-14-000006.txt   348811
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 14678238
SIC: 2834 Pharmaceutical Preparations